Lv41
696 积分 2021-03-16 加入
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
5小时前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
1个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
1个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
2个月前
已完结
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression
2个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial
2个月前
已完结
FGF21 reverses MASH through coordinated actions on the CNS and liver
3个月前
已完结
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
3个月前
已完结
FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease
4年前
已完结
Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response
4年前
已完结
皖公网安备34019202002308
